David Schladt

589 total citations
15 papers, 458 citations indexed

About

David Schladt is a scholar working on Transplantation, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, David Schladt has authored 15 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Transplantation, 10 papers in Surgery and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in David Schladt's work include Renal Transplantation Outcomes and Treatments (14 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Transplantation: Methods and Outcomes (7 papers). David Schladt is often cited by papers focused on Renal Transplantation Outcomes and Treatments (14 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Transplantation: Methods and Outcomes (7 papers). David Schladt collaborates with scholars based in United States, Egypt and Japan. David Schladt's co-authors include Ajay K. Israni, William S. Oetting, Robert Leduc, Pamala A. Jacobson, Arthur J. Matas, W. Guan, Vishal Lamba, Bruce A. Julian, Roslyn B. Mannon and Ann M. Brearley and has published in prestigious journals such as Transplantation, American Journal of Transplantation and The Journal of Heart and Lung Transplantation.

In The Last Decade

David Schladt

14 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Schladt United States 9 380 194 138 76 75 15 458
W. Guan United States 6 352 0.9× 212 1.1× 96 0.7× 86 1.1× 67 0.9× 8 420
Eduard M. Scholten Netherlands 7 393 1.0× 153 0.8× 154 1.1× 51 0.7× 114 1.5× 9 473
F. Villemain France 8 611 1.6× 175 0.9× 208 1.5× 77 1.0× 185 2.5× 13 757
Uwe Heeman Spain 7 256 0.7× 126 0.6× 153 1.1× 28 0.4× 79 1.1× 9 376
Ferdi Sombogaard Netherlands 9 310 0.8× 72 0.4× 58 0.4× 71 0.9× 84 1.1× 14 391
Elly M. van Duijnhoven Netherlands 9 512 1.3× 164 0.8× 283 2.1× 40 0.5× 150 2.0× 10 646
Jean Luc André France 7 192 0.5× 150 0.8× 44 0.3× 44 0.6× 34 0.5× 8 325
Pauline Houssel‐Debry France 14 244 0.6× 88 0.5× 299 2.2× 36 0.5× 44 0.6× 45 558
Timothy J. Schroeder United States 12 253 0.7× 82 0.4× 143 1.0× 21 0.3× 50 0.7× 19 388
Johannes van Hooff Netherlands 9 275 0.7× 130 0.7× 93 0.7× 43 0.6× 110 1.5× 12 381

Countries citing papers authored by David Schladt

Since Specialization
Citations

This map shows the geographic impact of David Schladt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Schladt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Schladt more than expected).

Fields of papers citing papers by David Schladt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Schladt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Schladt. The network helps show where David Schladt may publish in the future.

Co-authorship network of co-authors of David Schladt

This figure shows the co-authorship network connecting the top 25 collaborators of David Schladt. A scholar is included among the top collaborators of David Schladt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Schladt. David Schladt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Croy, Richard, et al.. (2022). Lung Transplant Outcomes in Adults in the United States: Retrospective Cohort Study Using Real-world Evidence from the SRTR. Transplantation. 106(6). 1233–1242. 10 indexed citations
3.
Hart, Allyson, David Zaun, Robbin Itzler, et al.. (2021). Cost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the US. Journal of Medical Economics. 24(1). 1011–1017. 10 indexed citations
4.
Croy, Richard, et al.. (2021). Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Data from the US Scientific Registry of Transplant Recipients (SRTR). The Journal of Heart and Lung Transplantation. 40(4). S165–S165.
5.
McKinney, Warren T., Cory R. Schaffhausen, Marilyn J. Bruin, et al.. (2020). Development of a Patient-specific Search of Transplant Program Outcomes and Characteristics: Feedback From Kidney Transplant Patients. Transplantation Direct. 6(8). e585–e585. 5 indexed citations
6.
Israni, Ajay K., Casey R. Dorr, David Schladt, et al.. (2015). Single nucleotide polymorphisms (SNPs) Associated with Acute Rejection in European American Kidney Transplant Recipients: a Genome Wide Association Study (GWAS). 1 indexed citations
7.
Israni, Ajay K., Robert Leduc, Pamala A. Jacobson, et al.. (2013). Inflammation in the setting of chronic allograft dysfunction post‐kidney transplant: phenotype and genotype. Clinical Transplantation. 27(3). 348–358. 12 indexed citations
8.
Israni, Ajay K., Robert Leduc, William S. Oetting, et al.. (2013). Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics. Transplant International. 26(10). 982–989. 54 indexed citations
9.
Jacobson, Pamala A., David Schladt, William S. Oetting, et al.. (2012). Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs. American Journal of Transplantation. 12(12). 3326–3336. 85 indexed citations
10.
Jacobson, Pamala A., David Schladt, Ajay K. Israni, et al.. (2012). Genetic and Clinical Determinants of Early, Acute Calcineurin Inhibitor-Related Nephrotoxicity. Transplantation. 93(6). 624–631. 57 indexed citations
11.
Jacobson, Pamala A., David Schladt, William S. Oetting, et al.. (2012). Reply to “Genetic Determinants of Mycophenolate-Related Anemia and Leukopenia After Transplantation”. Transplantation. 93(10). e41–e42. 7 indexed citations
12.
Jacobson, Pamala A., William S. Oetting, Ann M. Brearley, et al.. (2011). Novel Polymorphisms Associated With Tacrolimus Trough Concentrations: Results From a Multicenter Kidney Transplant Consortium. Transplantation. 91(3). 300–308. 134 indexed citations
13.
Jacobson, Pamala A., David Schladt, William S. Oetting, et al.. (2010). Genetic Determinants of Mycophenolate-Related Anemia and Leukopenia After Transplantation. Transplantation. 91(3). 309–316. 45 indexed citations
14.
Israni, Ajay K., Robert Leduc, John H. Holmes, et al.. (2010). Single-Nucleotide Polymorphisms, Acute Rejection, and Severity of Tubulitis in Kidney Transplantation, Accounting for Center-to-Center Variation. Transplantation. 90(12). 1401–1408. 36 indexed citations
15.
Kukla, Aleksandra, Robert Leduc, David Schladt, et al.. (2010). LATE ACUTE REJECTION - AN IMPACT ON THE LONG-TERM KIDNEY ALLOGRAFT SURVIVAL. Transplantation. 90. 865–865. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026